评估肝功能:Gd-EOB-DTPA增强MRI细胞外间隙期与肝胆期实质强化及肝体积比值的诊断效能
回顾性分析221例患者共303次Gd-EOB-DTPA增强MRI,计算T1序列注射后70秒(细胞外间隙期)和20分钟(肝胆期)肝-肌肉信号比并归一化肝体积。肝胆期归一化比值在肝硬化患者中显著低于非肝硬化患者,与Child-Pugh和MELD评分呈中度显著相关,且随Child-Pugh分级和MELD评分升高而逐渐降低;细胞外间隙期归一化比值与上述评分无相关性。
要点
- 肝胆期归一化肝-肌肉信号比(irHEPnorm)在肝硬化患者中显著低于非肝硬化患者(0.0004±0.0002 vs 0.0005±0.0003,p=0.010)。
- irHEPnorm与Child-Pugh评分(R=-0.292,p<0.0001)和MELD评分(R=-0.192,p=0.010)呈中度显著负相关。
- irHEPnorm从Child-Pugh A到C逐渐降低(0.0004-0.0002,p<0.0001),从MELD≤10到19-24逐渐降低(0.0004-0.0003,p=0.018)。
核心结论
- Gd-EOB-DTPA增强MRI得出的irHEPnorm值是一种可靠、无创、有用的工具,可量化肝功能和评估肝硬化程度,与临床评分和生化参数关系密切;这可能有助于外科医生临床决策,为肝硬化患者选择更合适的手术方式。
研究设计与样本
- 回顾性分析疑似肝脏病变患者的全部动态Gd-EOB-DTPA增强MRI检查,共纳入221例患者的303次MRI检查;计算T1序列注射Gd-EOB-DTPA后70秒(细胞外间隙期)和20分钟(肝胆期)肝-肌肉信号比,并归一化肝体积得到irINTnorm和irHEPnorm;采用Pearson相关系数评估这些值与Child-Pugh评分、MELD评分及生化检查的相关性。
诊断标准与关键数值
- irHEPnorm在肝硬化患者中为0.0004±0.0002,低于非肝硬化患者的0.0005±0.0003(p=0.010);irHEPnorm与Child-Pugh评分相关R=-0.292(p<0.0001),与MELD评分相关R=-0.192(p=0.010);irHEPnorm从Child-Pugh A到C逐渐降低(0.0004-0.0002,p<0.0001),从MELD≤10到19-24逐渐降低(0.0004-0.0003,p=0.018);总胆红素、GOT和 albumin 与irHEPnorm相关性最强(R分别为-0.258、-0.291和0.262,p<0.0001);irINTnorm与Child-Pugh和MELD评分无相关性。
临床应用与阅片要点
- 作者认为irHEPnorm可作为一种无创工具量化肝功能和评估肝硬化程度,可能有助于外科医生为肝硬化患者选择更合适的手术方式。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To assess the efficacy of signal intensity in interstitial and hepatobiliary phase normalized for liver volume, on gadolinium-ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance imaging (MRI) study, for the evaluation of liver function through the comparison with Child-Pugh (CP), model for end-stage liver disease (MELD), and biochemical tests.
METHODS: All dynamic Gd-EOB-DTPA MRI studies performed in patients with suspected liver lesions were retrospectively reviewed. The rate of liver-to-muscle ratio on T1 sequence 70 s (interstitial phase) and 20 min (hepatobiliary phase) after injection of Gd-EOB-DTPA was calculated for each MRI study and then normalized for liver volume (irINTnorm and irHEPnorm). Pearson correlation coefficient was computed to assess the correlation among these values and CP and MELD scores, and biochemical tests.
RESULTS: A total of 303 MRI studies, performed on 221 patients, were included. Mean age was 63.8 years ± 12.9 with a majority of male patients (186; 61.4%). A total of 186 out of 303 (61.4%) were cirrhotic patients. The irHEPnorm was significantly lower in cirrhotic than non-cirrhotic patients (0.0004 ± 0.0002 to 0.0005 ± 0.0003, p = 0.010). This value had a moderate, significant correlation with Child-Pugh and MELD scores (R = - 0.292, p < 0.0001 and R = - 0.192, p = 0.010, respectively). In particular, irHEPnorm progressively decreased from Child-Pugh A to C (0.0004-0.0002, p < 0.0001) and from MELD ≤ 10 to 19-24 (0.0004-0.0003, p = 0.018). Among biochemical parameters, total bilirubin, GOT, and albumin had the strongest correlation with irHEPnorm (R = - 0.258, - 0.291, and 0.262, p < 0.0001, respectively). No correlations were found between irINTnorm and CP and MELD scores.
CONCLUSION: irHEPnorm value derived from Gd-EOB-DTPA-enhanced MRI is a reliable, non-invasive, useful tool to quantify liver function and to assess the degree of cirrhosis, offering a strict relationship with clinical scores and biochemical parameters. This could help surgeons in clinical decision-making, allowing them to choose the more suitable surgical approach for cirrhotic patients.
引用
- Ippolito D, Pecorelli A, Famularo S, et al. Assessing liver function: diagnostic efficacy of parenchymal enhancement and liver volume ratio of Gd-EOB-DTPA-enhanced MRI study during interstitial and hepatobiliary phase. Abdom Radiol (NY). 2019. PMID: 30411177. doi:10.1007/s00261-018-1812-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。